As our sister publication GenomeWeb Daily News reported yesterday, VC funding is tough to come by these days for life science startups — second-quarter VC funding fell by 39 percent year over year, marking the fourth consecutive quarter in which life science investment fell.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Investment Boom

Defending Open Access

And Covered

Another Go-Round?

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.